The US Neurology Devices Market to Present Opportunities for Growth

Introduction

Some of the major markets like cardiovascular and orthopedic devices have witnessed immense innovation over the last decade in terms of procedural ease of use and catering to previously unmet needs. The advancement in interventional cardiology technology and grafting procedures for orthopedic applications has already achieved peaks. Both these markets are now saturated in terms of innovation and will be deemed as mature markets in the next five years. Many of the cardiovascular and orthopedic firms are now looking towards new areas in order to sustain or bolster growth. One such industry where GlobalData expects huge growth and investment opportunities in the future is neurology devices.

Major cardiovascular technologies such as cardiac rhythm management and stents are now being explored for use in conditions of the nervous system in an effort to create new growth opportunities. Recent market events show that competition within the neurovascular and neurostimulation device markets is on the rise. The market is currently dominated by traditionally cardiovascular device centric companies like Medtronic, Boston Scientific and St. Jude Medical. A look at the clinical trial scenario for neurostimulation devices and neurovascular stents reiterates this fact. The aforesaid companies together have over fifteen major clinical trials underway, investigating neurology devices for various indications.

Scope

- The study discusses the neurology devices market, presenting the factors that could have a positive impact on the market.
- It provides information on the three key markets – Neurostimulation Devices, Embolic Systems and Neurovascular Stents.

Highlights

Reasons to buy

- Be abreast of key events in the medical device industry
- Make informed decisions by understanding the rationale behind key events
- Align your market strategies with the events which can impact your business
- Develop proactive marketing strategies and business plans through real-time updates of pipeline products, technologies and financial deals

Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 The US Neurology Devices Market to Present Opportunities for Growth 5
2.1 Overview 5
2.2 Neurostimulation Devices: Promising to Treat a Wide Range of Neurological Diseases 6
2.2.1 Neurostimulation Devices, US, Revenue ($m) Forecast, 2008 – 2015 7
2.3 Embolization Coils: Large Target Patient Population to Drive the Market 8
2.3.1 Embolic Systems, US, Revenue ($m) Forecast, 2008 - 2015 9
2.4 Neurovascular Stents: Increasing Incidence of Intracranial Atherosclerotic Disease to Drive the Market 10
2.4.1 Neurovascular Stents, US, Revenue ($m) Forecast, 2008 – 2015 11
3 Appendix 12
3.1 GlobalData Research Methodology 12
3.2 Secondary Research 13
3.3 Primary Research 14
3.4 Models 14
3.5 Forecasts 15
3.6 Expert Panel Validation 15
3.7 Currency Conversion 16
3.8 Contact Us 17
3.9 Disclaimer 17
[Inhaltsverzeichnis ausblenden]

LIST OF TABLES

1.1 List of Tables
Table 1: Neurostimulation Devices, Revenue ($m), US, 2008 – 2015 7
Table 2: Embolic Systems, Revenue ($m), US, 2008 – 2015 9
Table 3: Neurovascular Stents, Revenue ($m), US, 2008 – 2015 11
Table 4: USD to Local Currency, Average Exchange Rate 2008 16
LIST OF FIGURES

1.2 List of Figures
Figure 1: Neurostimulation Devices, Revenue ($m), US, 2008 – 2015 7
Figure 2: Embolic Systems, Revenue ($m), US, 2008 – 2015 9
Figure 3: Neurovascular Stents, Revenue ($m), US, 2008 – 2015 11
Figure 4: GlobalData Methodology 13
[Tabellenverzeichnis ausblenden]